Pfizer is cutting costs, growing its core business, and trading at a deep discount despite looming patent losses and COVID ...

Pfizer (NYSE:PFE) and BioNTech (NASDAQ:BNTX) have gained a positive opinion from the European Medicines Agency’s Committee ...

While Pfizer's dividend yield is clearly much higher than Merck's, both have relatively attractive yields today. And you ...

This was the stock's third consecutive day of losses.

Performance Assessment Pfizer ( NYSE: PFE ) has sold off since my last update on the stock, but marginally outperformed the S&P 500 ( SPY ) ( SPX ) ( IVV ) ( VOO ) due to a tick up in the stock ...

Pfizer (PFE) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to consider some of the key factors that could influence the stock's performance in the ...

Pfizer’s revenue of $13.7 billion in Q1 reflected an 8% y-o-y decline. While Vyndaqel sales surged 33% to $1.5 billion, Paxlovid sales plunged 75% to $491 million. Also, Comirnaty, Pfizer’s ...

Shares of Pfizer Inc. PFE slipped 1.15% to $23.12 Thursday, on what proved to be an all-around poor trading session for the stock market, with the S&P 500 Index SPX falling 0.53% to 5,939.30 and ...